RaySearch Laboratories AB (publ) has announced that RayStation® is now in clinical use at the two proton centers currently established in Spain: Quirónsalud and Clínica Universidad de Navarra.
The two centers have invested in cutting-edge medical technology and software for proton therapy – an advanced, high-precision form of radiation therapy which is gaining ground as a treatment method for certain types of tumors. Both centers aim to give patients access to the best possible cancer care locally, thereby eliminating the need to travel abroad for proton therapy. They selected RayStation for its flexibility, accuracy and its wide range of tools. The treatment planning system offers groundbreaking features such as machine learning, multi-criteria optimization, ultrafast computation speed and support for adaptive radiation therapy.
Quirónsalud Hospital Group performed the country’s first proton therapy treatments in December 2019 at its newly opened proton therapy center in Madrid. The facility is equipped with the Proteus®ONE* compact proton therapy system from IBA.
Clínica Universidad de Navarra began treating patients with proton therapy at its Madrid site in April 2020, creating the first proton therapy unit within a comprehensive cancer center in Spain. The facility is the first European installation of Hitachi’s complete proton therapy system PROBEAT.
Juan María Pérez Moreno, PhD, medical physicist at Quirónsalud Proton Therapy Center, says: “Quironsalud is a cutting-edge facility that brings the benefits of highly precise PBS proton plans created with RayStation. Flexibility and a wide range of tools make RayStation a key element of our center. As a very dynamic system under continuous development and improvement, it will help us deliver optimal patient care in the future.”
Felipe Calvo, director of the proton therapy unit at Clínica Universidad de Navarra, says: “Our facility enables patient treatments with higher precision. Combining RayStation with CT, MRI and PET scanning gives us outstanding accuracy both in targeting tumors and sparing healthy tissue.”
Johan Löf, founder and CEO, RaySearch, says: “The efforts of medical professionals, supported by advances in technology, are making cancer treatments safer, more effective, and more personalized. Proton therapy is a key technique for the future, and we are very pleased to support these two pioneering centers with the latest advances in proton treatment planning. Together we are bringing the benefits of highly precise treatment to more patients in the country.
Quirónsalud is the leading hospital group in Spain. Following a merger with Germany’s Fresenius-Helios, it is now also the largest hospital group in Europe. Quirónsalud has over 60 years’ experience in caring for people’s health. Through first-class hospitals, world-renowned experts, cutting-edge medical technology, the highest safety standards and a strong commitment to quality, Quirónsalud provides each patient with unique and personalized care.
About Clínica Universidad de Navarra
Founded in 1962, Clínica Universidad de Navarra is a leading academic medical center recognized for its research and teaching work, skilled professionals and achievements in the treatment of highly complex pathologies. The center has developed a care model focused on the needs of patients and their families, which are at the center of its work and research. Clínica Universidad de Navarra has been ranked as a top private hospital in Spain, and among the 50 best hospitals in the world.
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets worldwide its treatment planning system RayStation and next-generation oncology information system RayCare*. Over 2,600 clinics in more than 65 countries use RaySearch software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.
RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare. By harmonizing treatment planning, we enable better care for cancer patients worldwide.
* Subject to regulatory clearance in some markets.
More information about RaySearch is available at www.raysearchlabs.com
For further information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8510530 00
Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59